$1.07 Billion is the total value of BRIDGER MANAGEMENT, LLC's 44 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 43.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SHC | Sell | SOTERA HEALTH CO | $36,501,000 | -6.2% | 1,506,454 | -3.4% | 3.41% | -6.3% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $26,192,000 | -17.9% | 2,035,114 | -28.7% | 2.44% | -17.9% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $20,607,000 | -14.1% | 1,325,188 | -20.6% | 1.92% | -14.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $18,868,000 | -41.0% | 111,304 | -50.9% | 1.76% | -41.0% |
| AMWL | Sell | AMERICAN WELL CORPcl a | $17,403,000 | -38.5% | 1,383,417 | -15.1% | 1.62% | -38.5% |
| HCA | Sell | HCA HEALTHCARE INC | $14,185,000 | -67.4% | 68,613 | -70.3% | 1.32% | -67.4% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $12,008,000 | -15.8% | 74,670 | -16.2% | 1.12% | -15.8% |
| TGTX | Sell | TG THERAPEUTICS INC | $8,503,000 | -31.3% | 219,197 | -14.7% | 0.79% | -31.3% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $7,332,000 | -47.3% | 116,015 | -64.2% | 0.68% | -47.3% |
| ACACW | Exit | ACIES ACQUISITION CORP*w exp 11/30/202 | $0 | – | -299,999 | -100.0% | -0.04% | – |
| Exit | DERMTECH INC | $0 | – | -122,877 | -100.0% | -0.58% | – | |
| ACAC | Exit | ACIES ACQUISITION CORPcl a | $0 | – | -899,997 | -100.0% | -0.84% | – |
| SQZ | Exit | SQZ BIOTECHNOLOGIES CO | $0 | – | -807,827 | -100.0% | -0.93% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -588,910 | -100.0% | -1.41% | – |
| FCNCA | Exit | FIRST CTZNS BANCSHARES INC Ncl a | $0 | – | -20,000 | -100.0% | -1.56% | – |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -114,289 | -100.0% | -2.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.